The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Olazax Disperzi

10 milligram(s) Orodispersible tablet

Glenmark Pharmaceuticals s.r.o.EU/1/09/592/003

Main Information

Trade NameOlazax Disperzi
Active SubstancesOlanzapine
Strength10 milligram(s)
Dosage FormOrodispersible tablet
Licence HolderGlenmark Pharmaceuticals s.r.o.
Licence NumberEU/1/09/592/003

Group Information

ATC CodeN05AH Diazepines, oxazepines, thiazepines and oxepines
N05AH03 olanzapine


Licence Issued
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing Status


Summary of Product CharacteristicsSearch EMA website
Package LeafletSearch EMA website
Public Assessment ReportSearch EMA website

Generics Information

Interchangeable List CodeIC0007-002-038
Interchangeable List DocumentPDF of Interchangeable List
« Back